Skip to main content
logo
Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
62.90
0.00 (0.00%)
Jul 30, 2026, 11:41 AM CST

Shine-On BioMedical Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-110.29-118.89-37.17-19.54-11.24
Depreciation & Amortization
2.071.871.691.520.82
Other Amortization
-0.320.230.110.03
Loss (Gain) From Sale of Assets
-0.41---
Loss (Gain) From Sale of Investments
--0.11---
Other Operating Activities
0.360.181.36-3.43-
Change in Accounts Receivable
-10-10--
Change in Accounts Payable
--2.862.86-2.08
Change in Other Net Operating Assets
-6.8817.6214.15-0.31-0.14
Operating Cash Flow
-114.75-91.45-26.88-21.66-8.46
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.03-0.11-0.07-0.48-2.25
Sale (Purchase) of Intangibles
-1.01-0.5-0.59-2.3-1.69
Investment in Securities
12636.11-242-712-108
Other Investing Activities
-4.43-0.14-0.6--0.38
Investing Cash Flow
120.5335.36-243.26-714.78-112.32

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-1.27-1.28-0.99-0.99-
Total Debt Repaid
-1.27-1.28-0.99-0.99-0.58
Net Debt Issued (Repaid)
-1.27-1.28-0.99-0.99-0.58
Issuance of Common Stock
---285.61,221
Financing Cash Flow
-1.27-1.28-0.99284.611,221

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
4.51-57.37-271.13-451.831,100

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-114.78-91.56-26.95-22.14-10.71
Free Cash Flow Growth
-----
Free Cash Flow Margin
-382.59%--282.94%--
Free Cash Flow Per Share
-2.30-1.84-0.54-0.49-0.58
Levered Free Cash Flow
-78.85-58.86-31.8-14.29-
Unlevered Free Cash Flow
-78.83-58.84-31.79-14.28-

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----0.02
Cash Income Tax Paid
-0.530.241.10.27-
Change in Working Capital
-6.8824.777.01-0.311.93